Sexual Silence in Breast Cancer Survivorship: A Secondary Qualitative Study of Healthcare Practices and Sexual Concerns Authors: Mina Esmkhani, Charrlotte Seib, Armin Ariana Published: 2026 ABSTRACT ABSTRACTBackground and AimsIn routine breast cancer follow‐up care, sexual concerns are rarely discussed, shaping how women understand and respond to post‐treatment changes. This study examined how survivorship care practices influence the expression and recognition of sexual concerns among women after breast cancer treatment.MethodsThis study employed a qualitative secondary analysis of semi‐structured interview data from 31 women aged 32–72 years who had completed primary treatment for breast cancer in Australia between 2025 and 2026. Data were re‐analysed using a reflexive thematic analysis approach to explore how healthcare interactions, clinical practices, and institutional conditions influence the expression of sexual concerns. Reporting was guided by the Standards for Reporting Qualitative Research.ResultsSexual silence was produced and normalised through routine omissions in care, fragmented pathways, and moral–cultural influences, reinforcing the marginalisation of sexual concerns. Sexual concerns were positioned as secondary to survival, limiting opportunities for discussion and support within survivorship care.ConclusionSexual distress after breast cancer is shaped by institutional practices that determine what is addressed in care and whose concerns are heard. Improving support requires greater attention to healthcare structures, professional roles, and cultural expectations shaping post‐treatment experiences.Keywords: breast neoplasms, cancer survivorship, health communication, qualitative research, sexual health Introduction Cancer survivorship care is increasingly organised around biomedical recovery, surveillance, and the management of long‐term treatment effects [1]. Follow‐up pathways prioritise disease monitoring, symptom control, and risk reduction, shaping clinical encounters through standardised objectives and time‐limited consultations [2, 3]. Within this configuration, aspects of survivorship that are less aligned with biomedical endpoints tend to receive less attention [4, 5]. In the context of survivorship care, sexuality occupies an ambiguous and weakly defined position. Although sexual wellbeing is widely acknowledged in policy statements and quality‐of‐life frameworks, it remains loosely integrated into routine follow‐up [6]. Clinical encounters frequently prioritise biomedical surveillance and treatment‐related outcomes, leaving limited space for addressing sexual concerns as part of standard care trajectories [7, 8]. Sexual concerns are reported following breast cancer treatment and are increasingly recognised within survivorship research [9]. Despite this recognition, post‐treatment sexual distress is frequently navigated without structured clinical pathways for guidance, validation, and acknowledgement [10, 11, 12]. In everyday clinical practice, attention remains directed toward disease surveillance and physical recovery, shaping care environments in which sexual wellbeing lacks consistent clinical engagement [13, 14]. This marginalisation constrains patients’ ability to express concerns, seek support, and participate meaningfully in their care. Existing survivorship literature has predominantly examined sexual difficulties through individualised frameworks, focusing on symptoms, functional outcomes, or personal coping processes [4, 12, 15, 16]. While this body of work has been instrumental in documenting the scope of post‐cancer sexual challenges, it often treats sexuality as a private or secondary concern, implicitly locating responsibility for adjustment within the individual survivor. What remains under‐examined is how sexual silence itself is produced and sustained through healthcare systems, clinical practices, and norms, shaping what is presented as unspeakable or clinically unnecessary [8, 17]. Within medical settings, silence can shape what is perceived as appropriate within clinical encounters, influencing which concerns are recognised. In the context of breast cancer, a gendered illness deeply entangled with cultural meanings of femininity, sexuality, and respectability, such silences are reinforced through moral and cultural expectations that frame sexual concerns as sensitive, inappropriate, or non‐essential to survival [18]. Breast cancer survivorship provides a critical site for examining the institutional production of sexual silence [7]. Survivorship care is often characterised by fragmented pathways and time‐limited consultations, creating conditions in which sexual wellbeing is routinely deferred or omitted [19]. Within these structures, women may be expected to self‐monitor, self‐advocate, or independently seek support for sexual concerns, effectively shifting responsibility away from healthcare systems and onto survivors themselves. These dynamics reproduce inequities, as access to sexual support becomes contingent on confidence, knowledge, and the capacity to articulate needs within environments that rarely invite such disclosures [7, 8]. While the broader qualitative dataset explored multiple dimensions of sexuality following breast cancer, including body image, sexual identity, partner relationships, and sociocultural influences, the present manuscript reports a planned secondary qualitative analysis focusing specifically on survivors’ experiences of healthcare communication, unmet sexual health needs, and barriers to accessing supportive care. This study explores how sexual silence develops and continues within breast cancer survivorship care. Using qualitative interview data, it moves the focus from individual experiences to the ways healthcare practices and systems shape what patients feel comfortable talking about. The findings show that sexual wellbeing is often treated as a lower priority, patient voices may be limited, and responsibility for addressing these concerns is often placed on patients themselves. This study adds to discussions on patient‐centred care by showing how healthcare systems influence what patients feel able to express. Methodology Study Design This study employed a qualitative secondary analysis [20], allowing re‐interpretation of an existing dataset to address a distinct research question while preserving the contextual integrity of participants’ narratives. This study is part of a larger doctoral research project examining sexual adjustment following breast cancer. While the primary analyses focused on women's embodied, relational, and identity‐based experiences of sexuality after treatment, the present study adopted a distinct analytic focus. Specifically, it re‐examined the dataset to explore how sexual concerns were shaped and constrained by survivorship care practices. The study was informed by an interpretive qualitative orientation, recognising that participants’ accounts of sexuality and care are shaped through personal, relational, and cultural contexts. The analysis aimed to examine how meanings around sexual wellbeing were produced and negotiated within survivorship care. Reporting was guided by established qualitative reporting standards, including the Standards for Reporting Qualitative Research [21]. Data Source and Participants The dataset comprised semi‐structured interviews with 31 women aged 32–72 years who had been diagnosed with Stage 0–IV breast cancer and had completed primary treatment in Australia between 2025 and 2026. Participants were recruited in Australia through oncology services and community networks as part of the broader doctoral project. The original interviews explored experiences of sexuality, intimacy, bodily change, and adjustment across survivorship. Participant characteristics are summarised in Table 1. Table 1Participant characteristics (N = 31).Characteristic n (%) or Mean (SD)Age (years)49.8 (9.3), range 32–72Time since diagnosis< 5 years22 (71%)5–10 years4 (13%)> 10 years5 (16%)Cancer stageStage 04 (13%)Stage I7 (23%)Stage II14 (45%)Stage III5 (16%)Stage IV1 (3%)Relationship statusPartnered30 (97%)Not partnered1 (3%)Treatment modalitySurgery28 (90%)Chemotherapy15 (48%)Radiotherapy14 (45%)Hormone therapy12 (39%) Note: Percentages may exceed 100% because participants could receive multiple treatment modalities. Participant characteristics (N = 31). Note: Percentages may exceed 100% because participants could receive multiple treatment modalities. For the present analysis, all transcripts were revisited in full, with focused attention to accounts referring to healthcare interactions, clinical communication, perceived omissions in care, and the social and moral contexts that influenced whether sexual concerns could be expressed. Participant characteristics, including age, treatment history, and time since diagnosis, were retained to support contextual interpretation, although the analytic emphasis in this study was on patterns across care experiences. The sample size was considered sufficient for the purposes of this analysis because recurring patterns relating to clinical silence, fragmented care, and the legitimacy of sexual concerns were identified across interviews during iterative re‐reading and coding. The present manuscript represents a secondary qualitative analysis of data collected as part of a broader doctoral qualitative study approved under the same ethics protocol. Although the interview guide explored multiple domains of post‐treatment sexuality, the current analysis focused specifically on participants’ accounts relating to healthcare communication, help‐seeking, access to sexual health care, and unmet supportive care needs. These topics were explicitly addressed within the original semi‐structured interview guide. Healthcare‐related material was identified from both the interview questions specifically addressing healthcare experiences (Questions 24–32) and from healthcare‐related narratives that emerged during discussions of other domains of sexuality. The complete semi‐structured interview guide is provided as Supporting File 1. Analytic Process The re‐analysis was conducted using an inductive, reflexive thematic analysis approach, informed by Braun and Clarke [22, 23]. Analysis was carried out in several iterative stages. First, all interview transcripts were re‐read in full to identify material related to healthcare experiences, clinical communication, and unmet sexual care needs. Relevant segments were then coded inductively, focusing on recurring practices, omissions, and patterns in how sexual concerns were addressed or left unaddressed within care. In the next stage, codes were reviewed, compared, and grouped to develop preliminary themes. These themes were refined through ongoing engagement with the data, with particular attention to how healthcare practices, cultural expectations, and moral assumptions shaped participants’ perceptions of whether sexual concerns were legitimate, discussable, or deserving of care. Through this process, the analysis moved beyond individual accounts to examine the broader conditions that contribute to sexual silence. All coding and analysis were conducted by the first author. A reflexive approach was maintained throughout, with ongoing attention to the researcher's role in interpretation and meaning‐making. Researcher Reflexivity The first author conducted the analysis and brought a background in women's health and sexuality research to the study. Reflexive practices included repeated return to the original transcripts, comparison between coded extracts and full narratives, and continued interrogation of how emerging interpretations were grounded in participants’ accounts. This approach supported analytic transparency while recognising interpretation as an active and situated process. Ethical Considerations Ethical approval for the original study was obtained from Griffith University, Australia. All participants provided written electronic informed consent for their interview data to be used in research and publication. To preserve confidentiality, participants were identified using study identification numbers. Results The analysis identified three interconnected themes that illustrate how sexual concerns are shaped and constrained within breast cancer survivorship care. Theme 1: Sexual Silence as a Normative Feature of Survivorship Care Participants reported a pattern in which sexual concerns were rarely addressed within routine follow‐up care. Across many interviews, the absence of discussion was experienced as a consistent feature of survivorship care. This contributed to a form of silence in which concerns remained unspoken, deferred, or managed privately. Accounts suggested that this silence was reinforced through routine clinical practices, including time‐limited consultations, prioritisation of biomedical outcomes, and the absence of prompts to discuss sexual health. As a result, participants often navigated changes in sexuality without guidance, shaping how these concerns were experienced and managed within survivorship. Silence and Sexual Taboos Sexuality was described as an unspoken or morally restricted domain. Participants reported learning that sexual matters should remain private, even within intimate relationships, leading many women to remain silent as their bodies changed after cancer. In my culture, we never talk about these things… when my body started changing, I stayed silent. (Participant 14, Stage II, 56 y) Women in our society are judged by appearance. I don't fit that anymore, and sometimes I feel invisible. (Participant 19, Stage I, 46 y) Although most participants expressed a desire for healthcare professionals to initiate conversations about sexual health, preferences regarding how these discussions should occur varied. Some women did not expect lengthy conversations but valued being offered a sensitive opportunity to raise concerns when they felt ready. I'm private but will share if asked — not in massive detail though. (Participant 22, Stage I, 42 y) Faith, Morality, and Purity Ideals Religious and moral frameworks strongly shaped how women interpreted sexual change. For some, faith provided meaning and resilience; for others, it intensified guilt and purity conflicts. I felt I had to purify myself before being intimate again. (Participant 16, Stage III, 49 y) For others, spirituality supported commitment to intimacy and relational care: I view sex as a way to strengthen intimacy… my worldview motivates me to keep trying. (Participant 7, Stage II, 51 y) “I told myself this is God's plan, maybe I am not meant to be that kind of woman anymore.” (Participant 5, Stage III, 53 y) These accounts illustrate the dual role of faith as both a source of support and a moral regulator of sexual expression. Family, Generational Expectations, and Beauty Norms Participants linked sexual self‐evaluation to generational messages about being a “good wife,” modest woman, or self‐sacrificing mother. My mother used to say a good wife doesn't complain. (Participant 24, Stage III, 58 y) Ideals of beauty further shaped sexual self‐perception. Breast loss, scarring, and asymmetry were experienced as deviations from femininity, reinforced by media and societal imagery. Even after reconstruction, I can't see myself the way I used to. (Participant 8, Stage II, 48 y) Younger and highly educated participants described a gradual shift toward openness and sexual wellbeing. My generation is more comfortable… sexuality is part of life. (Participant 30, Stage I, 48 y) Women positioned themselves between inherited norms of silence and emerging narratives of autonomy, negotiating continuity and change. Theme 2: Healthcare Practices Shaping the Legitimacy of Sexual Concerns Many narratives described pervasive dissatisfaction with post‐treatment care, particularly regarding sexuality. Across narratives, sexual concerns were marginalised within oncology settings, where survival was prioritised over quality of life. Narratives describing dissatisfaction were common among women aged 40–59 and those undergoing multimodal treatment. Educated participants more frequently framed these experiences as systemic failures rather than individual oversights. Silence and Neglect in Medical Communication Sexual side effects were rarely addressed unless raised by patients themselves. This absence of discussion reinforced a hierarchy of needs in which sexual wellbeing was treated as peripheral to recovery. It also limited opportunities for patients to express concerns and seek support within clinical encounters. No one has ever mentioned anything… they talked about saving my life, not living my life. (Participant 23, Stage II, 32 y) Gendered and Relational Barriers Participants suggested discomfort discussing intimacy with predominantly male clinicians and within highly formal consultations. He looked away when I tried to talk about pain during sex. (Participant 12, Stage I, 49 y) These dynamics were especially inhibiting for women from traditional or religious backgrounds, who internalised sexual distress as a private burden. Fragmentation and Unequal Access Care was described as fragmented, with limited continuity between oncology, primary care, and psychosocial services. No one looked at me as a whole person. (Participant 8, Stage II, 48 y) Access to sexual or psychological support was often restricted by cost, location, or availability, disproportionately affecting rural and lower‐income women. Advocacy and Self‐Navigation Some participants indicated becoming their own advocates, researching and initiating conversations about sexuality. If I don't ask, no one will tell me. (Participant 6, Stage I, 50 y) These patterns highlight how healthcare practices influence how patients interpret and respond to their sexual concerns. Although many participants described limited professional support, some responded by actively seeking information, initiating conversations, and advocating for their own sexual health needs. I learned to bring up sexuality myself. The system won't help you unless you make noise. (Participant 24, Stage III, 58 years) This account illustrates participants’ agency and self‐navigation; however, it also suggests that access to sexual health support often depended on women's confidence, knowledge, and capacity to advocate for themselves. Theme 3: Cultural and Moral Regulation of Sexual Expression Accounts indicated that sexual attitudes were shaped by cultural and relational expectations. These beliefs functioned as interpretive lenses, shaping responses to bodily change. The analysis indicated that traditional sexual attitudes were most salient among women aged 40–59, those undergoing mastectomy or multimodal treatment, and participants with lower education. Women from collectivist contexts described restraint and silence as core norms, whereas those from individualist cultures emphasised autonomy and communication. Patterns across participants suggested that cultural norms were particularly prominent among women aged 50–59 and 40–49, particularly those who had undergone surgical or multimodal treatment. Participants with lower education and moderate income more strongly adhered to traditional moral expectations, while highly educated women more often critically reflected on cultural taboos. Women from collectivist backgrounds described sexual silence as a culturally reinforced obligation, whereas those from individualist contexts articulated greater autonomy in redefining sexuality. Internalised Sexual Scripts Sexuality was frequently self‐regulated through internalised moral expectations, leading women to censor needs or emotions. Shame becomes a habit you carry even when the cancer is gone. (Participant 14, Stage II, 56 y) These scripts shaped whether bodily change was interpreted as loss, moral failure, or diminished femininity. Negotiating Meaning and Resistance Some participants actively questioned inherited norms, reframing sexuality around emotional connection, survivorship, and self‐acceptance. I now understand female sexuality can survive without breasts. (Participant 29, Stage 0, 69 y) This theme highlights sexuality as a culturally situated negotiation, shaped by silence, belief systems, and emerging resistance. Discussion The findings of this study suggest that sexual silence in breast cancer survivorship care is shaped by routine healthcare practices. Within clinical encounters, sexual wellbeing was often treated as a lower priority, which influenced how participants understood their own experiences. This lack of discussion limited patients’ ability to express concerns and seek support, shaping what could be recognised as a legitimate concern within care [7, 8, 24]. Importantly, this silence functioned as an organising feature of care that shaped how women interpreted their own experiences. When sexuality was not acknowledged within clinical encounters, many narratives described uncertainty about whether their concerns were valid, appropriate, or worthy of discussion. In this context, silence operated as a form of clinical communication, signalling that sexual distress was expected, unavoidable, or irrelevant to recovery. This extends existing survivorship research by demonstrating that silence reflects gaps in service provision and structures meaning‐making and legitimises the exclusion of sexual wellbeing from clinical attention [25, 26]. Participants’ accounts indicated that sexual care was rarely anchored within any specific clinical role, specialty, or pathway. These findings suggest that constraints on sexual communication in cancer care are less about individual clinician resistance and more about the absence of clear institutional ownership [6, 7, 27]. While existing studies frequently report that clinicians recognise the importance of sexual wellbeing but lack time, mandate, or structural support to address it, the present findings suggest that fragmentation in care makes it unclear who is responsible for addressing sexual concerns [4, 27]. Within this configuration, silence is reproduced through the absence of recognised pathways that would validate sexual care as part of survivorship. In contrast, some survivorship models emphasise patient self‐management and self‐advocacy, interpreting the absence of sexual discussion as reflecting patient reluctance or the prioritisation of survival‐related concerns [12, 15]. The present findings suggest that these explanations may be incomplete when considered without attention to the clinical conditions that shape whether patients perceive sexual concerns as legitimate or welcome topics of discussion. Participants’ reluctance to disclose was often shaped by the absence of professional invitations, limited consultation time, cultural expectations, and uncertainty regarding which healthcare professional was responsible for sexual care. These findings highlight how sexual silence is sustained through moral and cultural regulation operating within medical contexts. Narratives suggested sexuality as frequently framed as sensitive, inappropriate, or morally charged, particularly in relation to age, femininity, and survivorship expectations. These framings were rarely expressed through overt prohibition; instead, they were enacted through subtle cues, deflections, and normative assumptions embedded within everyday clinical interactions. Crucially, cultural and moral norms were enacted and reinforced through healthcare practices themselves. The absence of sexual discourse, combined with implicit expectations of gratitude for survival and resilience, contributed to care environments in which raising sexual concerns felt discordant with the moral tone of cancer care. In this way, clinical settings functioned as sites where broader cultural scripts surrounding femininity, respectability, and sexual restraint were reproduced and legitimised [27, 28]. These dynamics intersected with gendered assumptions embedded within breast cancer care, where sexual wellbeing was routinely treated as secondary to physical recovery. Within such hierarchies, sexual distress risked being interpreted as excessive or inappropriate, particularly when juxtaposed against narratives of successful treatment or remission. This moral positioning constrained women's capacity to articulate sexual needs, contributing to the internalisation of silence even in the absence of explicit discouragement. These findings complicate dominant survivorship narratives that frame self‐advocacy as inherently empowering. While prior literature often positions advocacy as a marker of resilience and agency, the present analysis suggests that within contexts of moral silence, self‐advocacy may instead signal systemic absence. When responsibility for sexual wellbeing is displaced onto survivors in the absence of proactive clinical engagement, advocacy becomes a form of adaptive labour. This reframing underscores the need to examine whether survivors speak up and the structural conditions that require them to do so. While participants consistently identified deficiencies in healthcare communication as an important contributor to unmet sexual health needs, their narratives also demonstrated that sexual wellbeing after breast cancer was shaped by a dynamic interaction of biological changes, psychological adaptation, intimate relationships, cultural expectations, faith, and personal agency. Consequently, healthcare communication should be understood as one important, yet modifiable, component within a broader biopsychosocial and sociocultural process of sexual adjustment rather than the sole determinant of survivorship outcomes. Integrating Institutional Silence, Moral Regulation, and Forced Self‐Advocacy Taken together, these findings illustrate that sexual silence after breast cancer is a dynamically organised process produced through the interaction of moral–cultural regulation and the displacement of responsibility onto survivors. These forces operate in concert, shaping the absence of sexual discourse as the conditions under which silence becomes normalised, anticipated, and internalised. Importantly, as moral silences converge, responsibility for sexual wellbeing is shifted onto women themselves, producing forms of self‐advocacy that are unevenly accessible and often emotionally costly. In this way, silence is sustained through an ongoing process in which survivors are required to compensate for systemic absence, thereby obscuring the structural origins of unmet sexual needs. This synthesis underscores that sexual distress after breast cancer cannot be fully understood by examining individual experiences or isolated clinical encounters alone. Instead, it emerges through a layered configuration in which institutional norms define the boundaries of care, cultural–moral scripts regulate what may be articulated, and self‐advocacy becomes a necessary response. By conceptualising silence as an organising mechanism that links these processes, the present study advances a structural account of post‐cancer sexual wellbeing, foregrounding the role of healthcare systems in shaping both what is addressed and who is required to speak. Clinical Implications Integrating sexual health into routine survivorship care may help to normalise these concerns and reduce the burden on patients to initiate discussions. This could include incorporating brief, standardised prompts about sexual wellbeing into follow‐up consultations, clarifying responsibility among healthcare providers (e.g., oncology teams, nurses, or primary care practitioners), and improving referral pathways to appropriate support services. Training clinicians to initiate and respond to sexual health concerns may also help to reduce discomfort and create a more open clinical environment. Sexual wellbeing should be acknowledged across the cancer continuum, including at diagnosis, during treatment planning, throughout active treatment, and in post‐treatment follow‐up. Brief and sensitive prompts may help normalise sexual concerns while allowing patients to decide whether and when they wish to discuss them. Recognising sexual health as part of quality‐of‐life outcomes aligns with person‐centred care principles and may contribute to improved psychosocial adjustment after cancer. Research Implications Future research should further examine how organisational structures, professional roles, and healthcare policies influence the inclusion of sexual health within cancer care. Studies incorporating the perspectives of healthcare professionals may provide additional insight into the constraints and opportunities for integrating sexual wellbeing into practice. Comparative research across cultural and healthcare contexts may also help to clarify how systemic and cultural dynamics interact to shape experiences of sexual silence. Longitudinal research may be particularly valuable in understanding how sexual concerns and communication patterns evolve over the survivorship trajectory, and how early clinical engagement may influence longer‐term outcomes. Conclusion This study suggests that sexual distress after breast cancer is shaped by institutional arrangements that render sexuality clinically marginal. Sexual silence operates as a systemic feature of care, structuring what is recognised as clinical concern and redistributing responsibility onto survivors themselves. Addressing sexual wellbeing therefore requires reconfiguring care pathways and clinical responsibilities so that sexual care is positioned as an integral component of person‐centred recovery. Strengths and Limitations The key strength of this study lies in its use of a rich qualitative dataset that enabled healthcare communication to be examined within the broader context of body image, intimacy, relationships, sexual identity, and sociocultural influences following breast cancer. This broader perspective allowed participants’ experiences of healthcare communication to be interpreted in relation to the wider realities of survivorship. Several limitations should be considered. Although healthcare communication was explored during the interviews, it was not the sole focus of the original study, limiting opportunities for more in‐depth exploration of some issues. As the interviews centred on sexuality after breast cancer, participants may have placed greater emphasis on communication challenges and unmet needs than on routine or positive healthcare experiences. In keeping with reflexive thematic analysis, the findings represent the interpretation of the first author. Finally, as the study was conducted in Australia, the transferability of the findings should be considered within comparable healthcare and sociocultural contexts. Author Contributions Mina Esmkhani: conceptualization, investigation, writing – original draft, methodology, visualization, software, formal analysis, data curation, resources. Charrlotte Seib: writing – review and editing, supervision, validation. Armin Ariana: supervision, writing – review and editing, validation, project administration. Ethics Statement This study received approval from the Griffith University Human Research Ethics Committee (GU ref no: 2024/871). Consent All participants provided written electronic informed consent prior to participation. Conflicts of Interest The authors declare no conflicts of interest. AI‐Disclosure AI‐assisted tools were used for language refinement. The authors take full responsibility for the content. Transparency Statement The lead author, Mina Esmkhani, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned have been explained. Supporting information Supporting File Acknowledgments We are deeply grateful to the women who entrusted us with their stories. Their willingness to share their experiences made this research possible. We also thank Richelle Menzies for her valuable assistance with data collection. We also acknowledge Griffith University for providing the academic environment and resources that supported this research. The first author was supported by the Griffith University Postgraduate Research Scholarship. The funder had no role in the study design, data collection, analysis, interpretation of the data, writing of the manuscript, or the decision to submit the manuscript for publication. Open access publishing facilitated by Griffith University, as part of the Wiley ‐ Griffith University agreement via the Council of Australasian University Librarians. Data Availability Statement Due to the sensitive nature of the qualitative data and ethical restrictions relating to participant confidentiality, the data are not publicly available. De‐identified excerpts may be made available from the corresponding author upon reasonable request, subject to ethical approval and institutional requirements. References Associated Data Supplementary Materials Supporting File Data Availability Statement Due to the sensitive nature of the qualitative data and ethical restrictions relating to participant confidentiality, the data are not publicly available. De‐identified excerpts may be made available from the corresponding author upon reasonable request, subject to ethical approval and institutional requirements.